Novavax Inc (NASDAQ:NVAX)

5.96
Delayed Data
As of Mar 20
 +0.03 / +0.50%
Today’s Change
5.68
Today|||52-Week Range
85.37
-42.02%
Year-to-Date
1 Green Flag and 1 Red Flag for Novavax
Mar 18 / MotleyFool.com - Paid Partner Content
1 Stock You Need to Sell Before the Next Bull Market
Mar 11 / MotleyFool.com - Paid Partner Content
Novavax (NVAX) Gains But Lags Market: What You Should Know
Mar 16 / Zacks.com - Paid Partner Content
Novavax Stock: Bear vs. Bull
Mar 10 / MotleyFool.com - Paid Partner Content
2 Growth Stocks That Are Trading at a Huge Discount Right Now -- Maybe Rightfully So
Mar 16 / MotleyFool.com - Paid Partner Content
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Mar 08 / MotleyFool.com - Paid Partner Content
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?
Mar 12 / MotleyFool.com - Paid Partner Content
Covid vaccine maker Novavax says it may not survive
Mar 01 / CNN.com

Today’s Trading

Previous close5.95
Today’s open5.80
Day’s range5.70 - 6.00
Volume3,265,598
Average volume (3 months)6,861,387
Market cap$514.5M
Data as of 3:59pm ET, 03/20/2023

Growth & Valuation

Earnings growth (last year)+64.09%
Earnings growth (this year)+34.50%
Earnings growth (next 5 years)-69.66%
Revenue growth (last year)+39.49%
P/E ratioNM
Price/Sales0.50
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRSNMersana Therapeutics...-0.27-5.78%
MORMorphoSys AG+0.09+2.36%
ALECAlector Inc+0.07+1.11%
SRRKScholar Rock Holding...-0.27-2.87%
Data as of 3:59pm ET, 03/20/2023

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)-$3.08
Annual revenue (last year)$1.6B
Annual profit (last year)-$657.9M
Net profit margin-41.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts